Section Arrow
Quote
DRRX.NASDAQ
- DURECT Corp
(Financial Status)
Quotes are at least 15-min delayed:2025/05/10 19:24 EDT
Last
 0.73
+0.074 (+11.28%)
Day High 
0.7335 
Prev. Close
0.656 
1-M High
0.786899 
Volume 
270.58K 
Bid
0.6901
Ask
0.6999
Day Low
0.63 
Open
0.65 
1-M Low
0.5231 
Market Cap 
20.36M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 0.61 
20-SMA 0.67 
50-SMA 0.75 
52-W High 1.88 
52-W Low 0.5231 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.27/-0.11
Enterprise Value
21.49M
Balance Sheet
Book Value Per Share
0.29
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.03M
Operating Revenue Per Share
0.63
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SHPHShuttle Pharmaceuticals Holdings Inc0.2325-0.0375-13.89%-- 
PTPIPetros Pharmaceuticals Inc0.1201-0.0053-4.23%-- 
VTRSViatris8.77-0.32-3.52%227.2PE
TEVATeva Pharmaceutical Industries Limited16.93-1.14-6.31%-- 
IXHLIncannex Healthcare0.1135+0.0009+0.80%-- 
Quotes are at least 15-min delayed：2025/05/10 19:24 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entitiesand proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.